First-episode schizophrenia. A window of opportunity for optimizing care and outcomes.

Peter F Buckley, Denise Evans

Research output: Contribution to journalReview article

21 Citations (Scopus)

Abstract

The pernicious course of schizophrenia has spurred efforts to identify and effectively treat this condition as early as possible. This assertive therapeutic stance is supported by epidemiologic data suggesting a substantial time lag between onset of illness and therapeutic intervention, and by neurobiologic data suggesting that brain changes present in first-episode psychosis are comparable to those in chronic schizophrenia. The proposal that atypical antipsychotic medications may prevent illness deterioration and/or be a restorative intervention is an appealing, but as yet unproven, hypothesis. Major challenges to maximizing treatment outcomes in first-episode schizophrenia include optimizing timing and effectiveness of pharmacologic interventions, service coordination, and access to care. We present data on the onset and presentation of first-episode schizophrenia and emerging findings about the neurobiology of first episodes, review nonpharmacologic and pharmacologic management, and summarize clinical research data on use of atypical antipsychotics in first-episode patients.

Original languageEnglish (US)
Pages (from-to)5-19
Number of pages15
JournalPostgraduate Medicine
VolumeSpec No
StatePublished - Jan 1 2006

Fingerprint

Schizophrenia
Antipsychotic Agents
Neurobiology
Psychotic Disorders
Brain
Therapeutics
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

First-episode schizophrenia. A window of opportunity for optimizing care and outcomes. / Buckley, Peter F; Evans, Denise.

In: Postgraduate Medicine, Vol. Spec No, 01.01.2006, p. 5-19.

Research output: Contribution to journalReview article

Buckley, Peter F ; Evans, Denise. / First-episode schizophrenia. A window of opportunity for optimizing care and outcomes. In: Postgraduate Medicine. 2006 ; Vol. Spec No. pp. 5-19.
@article{de3d52cdc98f45f0b59d04d473f5b310,
title = "First-episode schizophrenia. A window of opportunity for optimizing care and outcomes.",
abstract = "The pernicious course of schizophrenia has spurred efforts to identify and effectively treat this condition as early as possible. This assertive therapeutic stance is supported by epidemiologic data suggesting a substantial time lag between onset of illness and therapeutic intervention, and by neurobiologic data suggesting that brain changes present in first-episode psychosis are comparable to those in chronic schizophrenia. The proposal that atypical antipsychotic medications may prevent illness deterioration and/or be a restorative intervention is an appealing, but as yet unproven, hypothesis. Major challenges to maximizing treatment outcomes in first-episode schizophrenia include optimizing timing and effectiveness of pharmacologic interventions, service coordination, and access to care. We present data on the onset and presentation of first-episode schizophrenia and emerging findings about the neurobiology of first episodes, review nonpharmacologic and pharmacologic management, and summarize clinical research data on use of atypical antipsychotics in first-episode patients.",
author = "Buckley, {Peter F} and Denise Evans",
year = "2006",
month = "1",
day = "1",
language = "English (US)",
volume = "Spec No",
pages = "5--19",
journal = "Postgraduate Medicine",
issn = "0032-5481",
publisher = "Medquest Communications LLC",

}

TY - JOUR

T1 - First-episode schizophrenia. A window of opportunity for optimizing care and outcomes.

AU - Buckley, Peter F

AU - Evans, Denise

PY - 2006/1/1

Y1 - 2006/1/1

N2 - The pernicious course of schizophrenia has spurred efforts to identify and effectively treat this condition as early as possible. This assertive therapeutic stance is supported by epidemiologic data suggesting a substantial time lag between onset of illness and therapeutic intervention, and by neurobiologic data suggesting that brain changes present in first-episode psychosis are comparable to those in chronic schizophrenia. The proposal that atypical antipsychotic medications may prevent illness deterioration and/or be a restorative intervention is an appealing, but as yet unproven, hypothesis. Major challenges to maximizing treatment outcomes in first-episode schizophrenia include optimizing timing and effectiveness of pharmacologic interventions, service coordination, and access to care. We present data on the onset and presentation of first-episode schizophrenia and emerging findings about the neurobiology of first episodes, review nonpharmacologic and pharmacologic management, and summarize clinical research data on use of atypical antipsychotics in first-episode patients.

AB - The pernicious course of schizophrenia has spurred efforts to identify and effectively treat this condition as early as possible. This assertive therapeutic stance is supported by epidemiologic data suggesting a substantial time lag between onset of illness and therapeutic intervention, and by neurobiologic data suggesting that brain changes present in first-episode psychosis are comparable to those in chronic schizophrenia. The proposal that atypical antipsychotic medications may prevent illness deterioration and/or be a restorative intervention is an appealing, but as yet unproven, hypothesis. Major challenges to maximizing treatment outcomes in first-episode schizophrenia include optimizing timing and effectiveness of pharmacologic interventions, service coordination, and access to care. We present data on the onset and presentation of first-episode schizophrenia and emerging findings about the neurobiology of first episodes, review nonpharmacologic and pharmacologic management, and summarize clinical research data on use of atypical antipsychotics in first-episode patients.

UR - http://www.scopus.com/inward/record.url?scp=34547183567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547183567&partnerID=8YFLogxK

M3 - Review article

VL - Spec No

SP - 5

EP - 19

JO - Postgraduate Medicine

JF - Postgraduate Medicine

SN - 0032-5481

ER -